CLINICAL STUDY OF BABOOL (ACACIA ARABICA WILLD.) AND KUKUNDAR (BLUMEA LACERA D.C.) ON ASRIGDARA

Rakta is known to be a vital substance of body. As the disease is characterized by excess flow of blood out of the body, Raktastambhana Chikitisa is beneficial. Treatment prescribed for Raktatisara, Raktapitta, Raktarsha, Guhyaroga and Garbhasrava is also useful. Considering this aspect, Raktastambhaka, Raktsodhana, Raktapittaghna effects are desired in treatment. Haemostatic drugs should be used by giving due consideration to the association of Doshas diagnosed on the basis of colour and smell of the blood. Aims and Objectives: To evaluate the efficacy of Babool and Kukundar and comparative clinical study of Babool and Kukundar on Asrigdara. Materials and Methods: For the present study, patients fulfilling the clinical criteria for diagnosis of Asrigdara will be selected irrespective of their age, sex, religion, etc, in random from O.P.D. section of M. M. M. Govt. Ayurveda College hospital, Udaipur (Raj.). Case history of all the patients was taken in the specially prepared proforma. Conclusion: Babool due to its astringent taste and Kunkundar due to its bitter taste, both drugs pacify excessive Pitta humour which is main cause of Asrigdara. Their chemical constituents possess haemostatic and anti-inflammatory properties thus considering these facts, these drugs have been selected for present study

ATIVISA (ACONITUM HETEROPHYLLUM WALL EX. ROYLE): A COMPREHENSIVE REVIEW ON PROPAGATION, TRADITIONAL USES AND PHARMACOLOGY

Aconitum heterophyllum Wall ex. Royle is considered an important medicinal plant in traditional system of medicine as the tuberous roots are used for curing different ailments. But over grazing, prolong seed dormancy and many other reasons have led to the exploitation of this plant, so conservation through various modes is the need of the hour. Aims: The present review aims for accounting extensive information on different methods of propagation, traditional uses and pharmacological activities of Aconitum heterophyllum. Review Methods: A literature search was done on Aconitum heterophyllum using relevant Ayurvedic and contemporary texts. Different scientific databases such as Pubmed, Scopus, EBSCO, Google Scholar Information were used to collect all information regarding propagation and pharmacology of this plant. Results: Available data has reported that this endangered plant can be propagated through various methods such as raising propagules from seeds and daughter tubers, and other plant tissue culture techniques. Plant has reported to have 0.79% of total alkaloids in roots, out of which Atisine (0.4%), Heteratisine (0.3%), histisine, heterophyllisine, heterophylline, heterophyllidine are some major alkaloids. It also possesses important pharmacological activities like anti-bacterial activity, anti-diarrhoeal activity, enzyme-inhibition activity, anti-inflammatory activity, hepato-protective activity and anti-spasmodic activity. Conclusion: The results of this review clearly suggests about the valuable traditional use of Aconitum heterophyllum in curing various ailments like diarrhoea, dysentery, bilious complaints, intermittent fever and diseases of children. Further research: Different traditional uses mentioned in Āyurveda texts need further validation through different experimental and clinical studies which is a recommendation of this review

Bulk Level to Individual Particle Level Chemical Composition of Atmospheric Dust Aerosols (PM5) over a Semi-Arid Urban Zone of Western India (Rajasthan)

Mineral dust particles in the lower atmosphere may significantly influence radiative and optical budgets, along with the net chemical balance, through their interactions with ambient chemicals. Their ability to absotb/scatter incoming radiation strongly depends on their chemical composition (i.e., distribution of major crustal elements), but as yet there is no adequate regional database with regard to this for the Indian region. To create a regional database of background mineral dust from a semi-arid zone of western India, we measured the chemical composition of ambient particles (with aerodynamic diameter <= 5 mu m; PM5), collected from seven locations of Jaipur city (in the vicinity of Thar Desert; Rajasthan) at varying altitudes, during late-winter of 2012. The chemical compositions of the sampled particles at both bulk and individual levels were measured using X-ray fluorescence (XRF) and Scanning Electron Microscope equipped with Energy Dispersive X-ray (SEM-EDX) techniques, respectively. Significant differences in chemical compositions were observed among the seven sites, yet the bulk chemical compositions of the particles were broadly consistent with those of individual particles. Average elemental ratios of Mg/Al, Si/Al, K/Al, Ca/Al, Mn/Al, Fe/Al were found to be 0.44 +/- 0.22, 1.96 +/- 0.90, 0.65 +/- 0.22, 1.52 +/- 0.40, 0.84 and 1.54 +/- 1.67, respectively. We also estimated the complex refractive index (RIs at 550 nm wavelength) for the studied sites, yielding an average n and k (the real and imaginary parts of RI, respectively) of (1.56 +/- 0.03) + (6.5 +/- 4.6) x 10(-3)i, with the aerosols collected from Kukas Hill area (27.02 degrees N, 75.85 degrees E) having the highest iron (Fe) mass fraction (similar to 43%). Non-crustal elements e.g., Cu, S, C, Ag and Pb were found only in aerosols over the main city Birla Temple (Jaipur) at ground level (26.89 degrees N, 75.81 degrees E)

Morphology of Atmospheric Particles over Semi-Arid Region (Jaipur, Rajasthan) of India: Implications for Optical Properties

The regional dust morphology and spectral refractive indices (RIs; governed by hematite, Fe2O3 content at short wavelengths) are key elements for ascertaining direct radiative forcing of mineral dust aerosols. To provide morphological features of background mineral dust from a semi-arid zone in the vicinity of the Thar Desert, we carried out an expedition to the Jaipur city during late winter of 2012. Morphological analysis reveals the predominance of "Layered", "Angular" and "Flattened" particles, while the frequency distribution of a total of 235 dust particles shows the aspect ratio, AR and circularity parameter, CIR (measures of particle's non-sphericity) typically similar to 1.4 and similar to 0.8, respectively. Sensitivity analysis at 550 nm wavelength reveals the equivalent sphere model may underestimate Single Scattering Albedo, SSA for the dust with low (similar to 1.1%) hematite by similar to 3.5%. Both underestimation (by similar to 5.6%) and overestimation (up to 9.1%) are probable in case of dust with high hematite content (similar to 5.68%). In addition, the effect of AR on the dust scattering is significant in case of dust with high hematite content. More such regionally representative dust morphological data are required for better estimation of regional radiative forcing of mineral dust aerosols

Artificial Light at Night: A Global Threat to Plant Biological Rhythms and Eco-Physiological Processes

Light is crucial environmental factor for primary resource and signalling in plants and provide optimum fitness under fluctuating environments from millions of year. However, due to urbanization, and human development activities lot of excess light generated in environment during night time and responsible for anthropogenic generated pollution (ALAN; artificial night light pollution). This pollution has cause for serious problem in plants as it affects their processes and functions which are under the control of light or diurnal cycle. Plant biorhythms mostly diurnal rhythms such as stomatal movements, photosynthetic activity, and many more metabolic processes are under the control of period of light and dark, which are crucially affected by artificial light at night. Similarly, the crucial plant processes such as pollination, flowering, and yield determining processes are controlled by the diurnal cycle and ALAN affects these processes and ultimately hampers the plant fitness and development. To keep in mind the effect of artificial light at night on plant biorhythm and eco-physiological processes, this chapter will focus on the status of global artificial night light pollution and the responsible factors. Further, we will explore the details mechanisms of plant biorhythm and eco-physiological processes under artificial light at night and how this mechanism can be a global threat. Then at the end we will focus on the ANLP reducing strategies such as new light policy, advanced lightening technology such as remote sensing and lightening utilisation optimisation

Dynamics of Hot QCD Matter -- Current Status and Developments

The discovery and characterization of hot and dense QCD matter, known as Quark Gluon Plasma (QGP), remains the most international collaborative effort and synergy between theorists and experimentalists in modern nuclear physics to date. The experimentalists around the world not only collect an unprecedented amount of data in heavy-ion collisions, at Relativistic Heavy Ion Collider (RHIC), at Brookhaven National Laboratory (BNL) in New York, USA, and the Large Hadron Collider (LHC), at CERN in Geneva, Switzerland but also analyze these data to unravel the mystery of this new phase of matter that filled a few microseconds old universe, just after the Big Bang. In the meantime, advancements in theoretical works and computing capability extend our wisdom about the hot-dense QCD matter and its dynamics through mathematical equations. The exchange of ideas between experimentalists and theoreticians is crucial for the progress of our knowledge. The motivation of this first conference named "HOT QCD Matter 2022" is to bring the community together to have a discourse on this topic. In this article, there are 36 sections discussing various topics in the field of relativistic heavy-ion collisions and related phenomena that cover a snapshot of the current experimental observations and theoretical progress. This article begins with the theoretical overview of relativistic spin-hydrodynamics in the presence of the external magnetic field, followed by the Lattice QCD results on heavy quarks in QGP, and finally, it ends with an overview of experiment results.Comment: Compilation of the contributions (148 pages) as presented in the `Hot QCD Matter 2022 conference', held from May 12 to 14, 2022, jointly organized by IIT Goa & Goa University, Goa, Indi

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P &lt; 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

Neurodevelopmental disorders in children aged 2-9 years: Population-based burden estimates across five regions in India.

BACKGROUND: Neurodevelopmental disorders (NDDs) compromise the development and attainment of full social and economic potential at individual, family, community, and country levels. Paucity of data on NDDs slows down policy and programmatic action in most developing countries despite perceived high burden. METHODS AND FINDINGS: We assessed 3,964 children (with almost equal number of boys and girls distributed in 2-<6 and 6-9 year age categories) identified from five geographically diverse populations in India using cluster sampling technique (probability proportionate to population size). These were from the North-Central, i.e., Palwal (N = 998; all rural, 16.4% non-Hindu, 25.3% from scheduled caste/tribe [SC-ST] [these are considered underserved communities who are eligible for affirmative action]); North, i.e., Kangra (N = 997; 91.6% rural, 3.7% non-Hindu, 25.3% SC-ST); East, i.e., Dhenkanal (N = 981; 89.8% rural, 1.2% non-Hindu, 38.0% SC-ST); South, i.e., Hyderabad (N = 495; all urban, 25.7% non-Hindu, 27.3% SC-ST) and West, i.e., North Goa (N = 493; 68.0% rural, 11.4% non-Hindu, 18.5% SC-ST). All children were assessed for vision impairment (VI), epilepsy (Epi), neuromotor impairments including cerebral palsy (NMI-CP), hearing impairment (HI), speech and language disorders, autism spectrum disorders (ASDs), and intellectual disability (ID). Furthermore, 6-9-year-old children were also assessed for attention deficit hyperactivity disorder (ADHD) and learning disorders (LDs). We standardized sample characteristics as per Census of India 2011 to arrive at district level and all-sites-pooled estimates. Site-specific prevalence of any of seven NDDs in 2-<6 year olds ranged from 2.9% (95% CI 1.6-5.5) to 18.7% (95% CI 14.7-23.6), and for any of nine NDDs in the 6-9-year-old children, from 6.5% (95% CI 4.6-9.1) to 18.5% (95% CI 15.3-22.3). Two or more NDDs were present in 0.4% (95% CI 0.1-1.7) to 4.3% (95% CI 2.2-8.2) in the younger age category and 0.7% (95% CI 0.2-2.0) to 5.3% (95% CI 3.3-8.2) in the older age category. All-site-pooled estimates for NDDs were 9.2% (95% CI 7.5-11.2) and 13.6% (95% CI 11.3-16.2) in children of 2-<6 and 6-9 year age categories, respectively, without significant difference according to gender, rural/urban residence, or religion; almost one-fifth of these children had more than one NDD. The pooled estimates for prevalence increased by up to three percentage points when these were adjusted for national rates of stunting or low birth weight (LBW). HI, ID, speech and language disorders, Epi, and LDs were the common NDDs across sites. Upon risk modelling, noninstitutional delivery, history of perinatal asphyxia, neonatal illness, postnatal neurological/brain infections, stunting, LBW/prematurity, and older age category (6-9 year) were significantly associated with NDDs. The study sample was underrepresentative of stunting and LBW and had a 15.6% refusal. These factors could be contributing to underestimation of the true NDD burden in our population. CONCLUSIONS: The study identifies NDDs in children aged 2-9 years as a significant public health burden for India. HI was higher than and ASD prevalence comparable to the published global literature. Most risk factors of NDDs were modifiable and amenable to public health interventions

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation